Description
Treatment with Voltaflam 50mg involves using this anti-inflammatory pill which belongs to the NSAIDs remedy class and performs through Diclofenac Sodium as its main chemical element. Manufactured by Dr. Reddy’s Laboratories Limited Company Voltaflam 50mg functions as a management treatment for conditions that experience pain and inflammation mostly affecting arthritis patients along with those experiencing muscle and backache as well as sprains and menstrual cramps.
Mechanism of Action
Diclofenac blocks inflammation through its inhibition of cyclooxygenase (COX) enzyme responsible for producing these inflammatory substances. The body uses prostaglandin generation through this enzyme to create chemicals which trigger pain symptoms along with fevers and inflammation. Voltaflam works through the inhibition of COX meaning that the formation of these prostaglandins is well curtailed and therefore managing of pains and swelling is achieved.
Key Properties
Active Ingredient: Diclofenac Sodium 50mg
Dosage Form: Tablet
Category: Non-steroidal anti-inflammatory drug (NSAID)
Manufacturer: Dr. Reddy’s Laboratories Ltd
Benefits
- This medicine provides fast pain relief for managing mild and moderate discomfort.
- Medicinal relief occurs through improved mobility while simultaneously reducing swelling.
- Effective in both acute and chronic conditions.
- In some cases, it is applied in the treatment of fever when other products are not efficient.
Common Side Effects
The pill appears to be relatively safe; however, the following side effects may occur in some patients:
- Nausea
- Stomach discomfort
- Headache
- Dizziness
- Indigestion
Conclusion
Voltaflam 50mg is a solution containing Diclofenac sodium as an active ingredient, made by Dr. Reddy’s Laboratories Ltd., that is used for the treatment of a variety of pain and inflammation complications that affects patients. But it must be consumed with medical advice, especially for people who have gastritis, kidney, or cardiovascular problems.
Reviews
There are no reviews yet.